Report Clear cell renal cell carcinoma with BAP1 mutation: a report of two cases

被引:0
|
作者
Lee, Jennifer [1 ,2 ]
Thuzar, Moe [1 ,2 ]
DiPoto-Brahmbhatt, Angela C. [1 ,2 ]
Chaudoir, Catherine [1 ,2 ]
Tanner, Anthony [1 ]
Fazili, Tajammul [3 ,4 ]
Yu, Xiuping [4 ,5 ]
Constantinescu, Michael [1 ,2 ]
Yeh, Y. Albert [1 ,2 ,4 ]
机构
[1] Overton Brooks VA Med Ctr, Pathol & Lab Med Serv, 510 East Stoner Ave, Shreveport, LA 71101 USA
[2] Louisiana State Univ Hlth Shreveport, Dept Pathol & Translat Pathobiol, Shreveport, LA USA
[3] Overton Brooks VA Med Ctr, Dept Urol, Shreveport, LA USA
[4] Louisiana State Univ Hlth Shreveport, Dept Urol, Shreveport, LA USA
[5] Louisiana State Univ Hlth Shreveport, Dept Biochem & Mol Biol, Shreveport, LA USA
关键词
Clear cell renal cell carcinoma; BAP1; mutation; eosinophilic granules; hyaline globules; TUMOR-SUPPRESSOR; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Clear cell renal cell carcinoma is the most common subtype of renal cell carcinomas (RCCs) and accounts for 60%-70% of all RCCs cases in adults. Aberrations in the von Hippel-Lindau (VHL) gene on chromosome 3p occurred in > 90% of clear cell RCCs. Other tumor suppressor genes located on chromosome 3p, such as BAP1, PBRM1, and SETD2, also contribute to tumorigenesis. Clear cell RCCs with both BAP1 and VHL mutations may display distinctive histopathological features. Here, we report two cases of clear cell RCCs with BAP1 mutation. One tumor had VHL, BAP-1, and RAF1 mutations and the tumor nests and alveoli of tumor cells were surrounded by proliferative vessels and the optically clear cytoplasm contained numerous eosinophilic granules and hyaline globules of varying sizes. The other tumor had BAP1 and ATM mutations, and demonstrated clear cells with numerous eosinophilic granules and other typical histopathological features of conventional clear cell RCC. Furthermore, many tumor nodules with dense peripheral lymphocytic infiltrates contained rhabdoid cells. Sarcomatoid cells were also observed. Both tumor cells showed high-grade nuclei. Clear cell RCCs with BAP1 mutation exhibit aggressive clinical behaviors.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [31] Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma
    Bihr, Svenja
    Ohashi, Riuko
    Moore, Ariane L.
    Ruschoff, Jan H.
    Beisel, Christian
    Hermanns, Thomas
    Mischo, Axel
    Corro, Claudia
    Beyer, Jorg
    Beerenwinkel, Niko
    Moch, Holger
    Schraml, Peter
    NEOPLASIA, 2019, 21 (02): : 247 - 256
  • [32] ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Reva, Boris
    Schultz, Nikolaus
    Chen, Ying-Bei
    Gonen, Mithat
    Liu, Han
    Takeda, Shugaku
    Tickoo, Satish K.
    Voss, Martin H.
    Cheng, Emily H.
    Reuter, Victor E.
    Motzer, Robert J.
    Russo, Paul
    Hsieh, James J.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E438 - E438
  • [33] BAP1 loss defines a new class of renal cell carcinoma
    Samuel Peña-Llopis
    Silvia Vega-Rubín-de-Celis
    Arnold Liao
    Nan Leng
    Andrea Pavía-Jiménez
    Shanshan Wang
    Toshinari Yamasaki
    Leah Zhrebker
    Sharanya Sivanand
    Patrick Spence
    Lisa Kinch
    Tina Hambuch
    Suneer Jain
    Yair Lotan
    Vitaly Margulis
    Arthur I Sagalowsky
    Pia Banerji Summerour
    Wareef Kabbani
    S W Wendy Wong
    Nick Grishin
    Marc Laurent
    Xian-Jin Xie
    Christian D Haudenschild
    Mark T Ross
    David R Bentley
    Payal Kapur
    James Brugarolas
    Nature Genetics, 2012, 44 : 751 - 759
  • [34] A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma
    Wadt, K. A. W.
    Aoude, L. G.
    Johansson, P.
    Solinas, A.
    Pritchard, A.
    Crainic, O.
    Andersen, M. T.
    Kiilgaard, J. F.
    Heegaard, S.
    Sunde, L.
    Federspiel, B.
    Madore, J.
    Thompson, J. F.
    McCarthy, S. W.
    Goodwin, A.
    Tsao, H.
    Jonsson, G.
    Busam, K.
    Gupta, R.
    Trent, J. M.
    Gerdes, A. -M.
    Brown, K. M.
    Scolyer, R. A.
    Hayward, N. K.
    CLINICAL GENETICS, 2015, 88 (03) : 267 - 272
  • [35] PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
    Joseph Walton
    Keith Lawson
    Panagiotis Prinos
    Antonio Finelli
    Cheryl Arrowsmith
    Laurie Ailles
    Nature Reviews Urology, 2023, 20 : 96 - 115
  • [36] PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
    Brugarolas, James
    CANCER JOURNAL, 2013, 19 (04): : 324 - 332
  • [37] Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma
    Miura, Yuji
    Inoshita, Naoko
    Ikeda, Masaomi
    Miyama, Yu
    Oki, Ryosuke
    Oka, Suguru
    Kondoh, Chihiro
    Ozaki, Yukinori
    Tanabe, Yuko
    Kurosawa, Kazuhiro
    Urakami, Shinji
    Kohno, Tadasu
    Okaneya, Toshikazu
    Takano, Toshimi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (06) : 386 - 391
  • [38] BAP1 loss defines a new class of renal cell carcinoma
    Pena-LlopiS, Samuel
    Vega-Rubin-de-Celis, Silvia
    Liao, Arnold
    Leng, Nan
    Pavia-Jimenez, Andrea
    Wang, Shanshan
    Yamasaki, Toshinari
    Zhrebker, Leah
    Sivanand, Sharanya
    Spence, Patrick
    Kinch, Lisa
    Hambuch, Tina
    Jain, Suneer
    Lotan, Yair
    Margulis, Vitaly
    Sagalowsky, Arthur I.
    Summerour, Pia Banerji
    Kabbani, Wareef
    Wong, S. W. Wendy
    Grishin, Nick
    Laurent, Marc
    Xie, Xian-Jin
    Haudenschild, Christian D.
    Ross, Mark T.
    Bentley, David R.
    Kapur, Payal
    Brugarolas, James
    NATURE GENETICS, 2012, 44 (07) : 751 - U174
  • [39] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Jeanette E. Eckel-Passow
    Daniel J. Serie
    John C. Cheville
    Thai H. Ho
    Payal Kapur
    James Brugarolas
    R. Houston Thompson
    Bradley C. Leibovich
    Eugene D. Kwon
    Richard W. Joseph
    Alexander S. Parker
    BMC Urology, 17
  • [40] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    BMC UROLOGY, 2017, 17 : 1 - 7